Written questions by MacCleary.

Food and Rural Affairs, whether his Department plans to introduce a ban on the import of animal fur.

I refer the Honourable Member to the reply I gave to PQ 958.

Food and Rural Affairs, whether his Department plans to take steps to reduce the amount of per- and polyflouroalkyl substances (PFAS) in drinking water.

The Drinking Water Inspectorate’s (DWI) current guideline limit on individual types of PFAS of 100 nanograms per litre for treated drinking water was set in 2021 based on an assessment of existing scientific knowledge. These limits were agreed with the UK Health Security Agency to be robust levels with an appropriate margin to ensure our drinking water is not a danger to human health. Work now continues across Government to assess levels of PFAS to safeguard current high drinking water quality and ensure our regulations remain fit for purpose. More widely, as we look to improve and maintain our water quality standards, this Government has been clear that vital infrastructure investment is ringfenced and can only be spent on upgrades benefiting customers and the environment. When money for investment is not spent, companies must refund customers, with money never allowed to be diverted for bonuses, dividends or salary increases. The Water (Special Measures) Bill will also deliver on the Government’s manifesto commitment to put water companies under special measures to clean up our water. Through the Bill, we will drive meaningful improvements in the performance and culture of the water industry.

Food and Rural Affairs, whether his Department plans to introduce a ban on the import of foie gras.

This Government shares the British public’s high regard for animal welfare. Foie gras production using force feeding has been banned in the UK for 17 years and it is not compatible with our animal welfare legislation. This Labour Government will introduce the most ambitious programme for animal welfare in a generation. Ministers are reviewing policies, which will be announced in due course.

If his Department will take steps to end the granting of licenses for hunting on its land.

No licences have yet been issued for trail hunting on the Ministry of Defence Estate for the 2024–2025 season.

Whether the proposed restrictions on puberty blockers will apply to those already using these medications.

In May 2024, a three-month emergency order restricting the sale and supply of Gonadotrophin-Releasing Hormone Analogues (puberty blockers) was introduced in Great Britain and was due to expire on 2 September 2024.On 22 August 2024, the Government laid a further Order to renew the restrictions in Great Britain. As the Northern Ireland First Minister and Deputy First Minister provided their agreement for the Minister of Health to co-sign the order, the restrictions also extend to Northern Ireland for the first time.Ensuring that care is safe, evidence-based and appropriate was the driving force behind the decision by my rt. Hon. Friend, the Secretary of State for Health and Social Care. The Cass Review was categorically clear that there is not enough evidence on the long-term impact of using puberty blockers to treat gender incongruence to know whether they are safe or if children benefit from them.The Order prohibits the sale and supply of puberty blockers for any purposes to those under 18 against prescriptions from prescribers registered in the European Economic Area (EEA) or Switzerland. For private prescriptions issued from registered prescribers in the United Kingdom, the Order prohibits the sale or supply of puberty blockers for gender incongruence or dysphoria to children under 18 years old not already on a course of treatment with them. Patients receiving these medicines for other uses, for example precocious puberty, can continue to access them.If a young person has already been prescribed these medicines, for gender dysphoria or incongruence in the six months prior to 3 June 2024 in Great Britain or 27 August 2024 in Northern Ireland, they can continue to do so, providing their prescription is now issued by a UK registered prescriber. They are strongly advised to meet with their prescribing clinician to fully understand the safety risks. For those patients accessing prescriptions from an EEA registered prescriber, they can seek help from a UK private provider or see their general practitioner.